Delray Medical Center WATCHMAN FLX Device for Atrial Fibrillation Now Offered to Patients

Northwell Health Ranked Nation’s Top Health System for Diversity

New York State’s largest health care provider and private employer made the list for the ninth straight year and remained in the top spot in the 2021 DiversityInc rankings for Hospitals and Health Systems.

ZAP Surgical and Swiss Neuro Radiosurgery Center Announce Imminent Installation of New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thus eliminating the significant costs to license, secure and regularly replace live radioactive isotopes.

Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

Sherwood's experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies.

November 9, 2020

Delray Medical Center now offers the WATCHMAN FLX™ for patients who have a high risk of stroke with non-valvular atrial fibrillation (NVAF) who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage-the area of the heart where stroke-causing blood clots commonly form in NAVF.

Delray Medical Center Dr. Martin Kloosterman, electrophysiologist on staff said, “People with atrial fibrillation are at an increased risk of stroke if they are not on blood thinners, which can also increase the risk of bleeding. This can often result in higher mortality and disability rates because of an injury to the brain or other affected areas.” He added, “We are pleased to have available a new generation of the Watchman FLX device, which expands the number of patients who can benefit from this life-saving technology.”

This technology features a new, fully rounded design offering physicians the ability to safely enter, and maneuver within the left atrial appendage.  It is the first LAAC device that can be fully recaptured, repositioned and redeployed for precise placement, and the new frame design allows for optimal device engagement with the tissue for long-term stability and a faster, more complete seal.

“This advanced technology gives us a new option to treat patients who are at high risk for stroke, that could also enable them to have a better long-term quality of life,” said Maggie Gill, chief executive officer for the Palm Beach Health Network and Delray Medical Center. “We remain committed to providing patients in Palm Beach County with comprehensive cardiovascular treatment options close to home, and in a safe environment.”

Atrial Fibrillation is a common heart disorder which occurs when electrical signals in the heart become irregular, causing the heart’s upper chamber to beat out of rhythm.  Atrial fibrillation requires immediate medical attention because it could lead to a life-threatening stroke, which is otherwise preventable.

When it comes to you, your family, and your health, Delray Medical Center and its cardiovascular team knows what it take to give you the care you need quickly and compassionately.  During a health emergency, you need health care you can trust.  At Delray Medical Center, we believe that is exactly what you will find.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles